Artículo
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
Schmid, Edward T.; Pang, Iris K.; Carrera Silva, Eugenio Antonio
; Bosurgi, Lidia; Miner, Jonathan J; Diamond, Michael S; Iwasaki, Akiko; Rothlin, Carla
Fecha de publicación:
06/2016
Editorial:
eLife Sciences Publications
Revista:
eLife
ISSN:
2050-084X
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
The receptor tyrosine kinase (RTK) AXL is induced in response to type I interferons (IFNs) and limits their production through a negative feedback loop. Enhanced production of type I IFNs in Axl(-/-) dendritic cells (DCs) in vitro have led to speculation that inhibition of AXL would promote antiviral responses. Notwithstanding, type I IFNs also exert potent immunosuppressive functions. Here we demonstrate that ablation of AXL enhances the susceptibility to infection by influenza A virus and West Nile virus. The increased type I IFN response in Axl(-/-) mice was associated with diminished DC maturation, reduced production of IL-1β, and defective antiviral T cell immunity. Blockade of type I IFN receptor or administration of IL-1β to Axl(-/-) mice restored the antiviral adaptive response and control of infection. Our results demonstrate that AXL is essential for limiting the immunosuppressive effects of type I IFNs and enabling the induction of protective antiviral adaptive immunity.
Palabras clave:
Axl
,
Dendritic Cells
,
Antiviral Response
,
T Cell
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(IMEX)
Articulos de INST.DE MEDICINA EXPERIMENTAL
Articulos de INST.DE MEDICINA EXPERIMENTAL
Citación
Schmid, Edward T.; Pang, Iris K.; Carrera Silva, Eugenio Antonio; Bosurgi, Lidia; Miner, Jonathan J; et al.; AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity; eLife Sciences Publications; eLife; 5; 6-2016; 1-18
Compartir
Altmétricas